Oncology Updates with ASCO Highlights - St. Louis

Saturday, June 21, 2025, 7:30 AM - 3:45 PM, DoubleTree by Hilton Hotel - St. Louis, St. Louis, MO


AMA PRA Category 1 Credits™ (5.75 hours), ACPE Contact Hours (5.75 hours), ANCC Contact Hours (5.75 hours), IPCE Credits (5.75 hours), Non-Physician Attendance (5.75 hours)

The Oncology Updates with ASCO Highlights- St. Louis is planned and implemented interprofessionally by physicians, nurses, and pharmacists. This in-person activity is designed for physicians, nurses, and pharmacists working in the areas of medical oncology, hematology, pathology, radiation oncology, radiology, neurology, hospital, internal, general, geriatric and family medicine or surgery (general, oncology, thoracic, colorectal and urology). It may also be of interest to physician assistants and other health professionals who care for cancer patients. The course will include multiple presentations developed based on new information presented at the ASCO Annual Meeting.

These presentations will be placed in the context of updates in treating and diagnosing malignant diseases, with particular highlights in Genitourinary, Gastrointestinal, Lung, Breast, and Head and Neck Cancer, CNS Tumors, Melanoma, Sarcoma, Lymphoma and will provide a Toxicity Update. The format will be didactic with question and answer panel discussion sections. The intended result of this activity is increased knowledge, competence, performance and enhanced patient care.

1. Summarize recent and emerging data from key studies in clinical and translational cancer research for the following areas; breast cancer; genitourinary cancer; gastrointestinal tract cancer; lung cancer, central nervous system tumors, sarcomas, melanomas and lymphomas.
2. Implement strategies designed to improve the quality of cancer care, address barriers to optimal care, enhance the patient experience and improve communication within the medical team
3. Report and share information about the newest clinical trials available for patients with different malignancies, or specific genetic mutations indicative of possible drivers for tumors. Apply results of recent trials and future trials
4. Improve strategies and communication skills to work with a multi-disciplinary team, including nurse practioners, nurses, and clinical pharmacists, to better communicate with patients in order to assess toxicity from cancer-directed therapies and improve patient quality of life.
5. Manage toxicities of newer cancer therapies

In support of improving patient care, Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Cancellation Policy

Cancellations received in writing no less than 20 days before the course will be refunded, less a 20% administrative fee. No refunds will be made on cancellations received after that date. Please send cancellation requests to [email protected].

Master Healthcare System reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

Accessibility Statement
 
Master Healthcare System is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

DoubleTree by Hilton Hotels - Chesterfield, MO

Mitigation of Relevant Financial Relationships

Master Continuing Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Saturday, June 21, 2025

Test